Helus Pharma Inc. Common Stock
HELP
46 hedge funds and large institutions have $64.6M invested in Helus Pharma Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 55 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.71% less ownership
Funds ownership: 38.05% → 36.34% (-1.7%)
18% less capital invested
Capital invested by funds: $78.4M → $64.6M (-$13.8M)
44% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 18
53% less funds holding
Funds holding: 98 → 46 (-52)
91% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 55
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$5.61M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$3.96M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.57M |
| 4 |
PP
PDS Planning
Dublin,
Ohio
|
+$2.35M |
| 5 |
Jane Street
New York
|
+$188K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$11.9M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
-$4.48M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$666K |
| 4 |
ACM
Altium Capital Management
New York
|
-$497K |
| 5 |
PBM
Propel Bio Management
Los Angeles,
California
|
-$230K |
HELP Hedge Fund Activity: Q3 2024 in Review
46 of the 6,982 institutional investors tracked by Wall St. Rank reported a position in Helus Pharma Inc. Common Stock (HELP) for Q3 2024, worth a combined $64.6M — down 18% from $78.4M a quarter earlier.
Sellers outnumbered buyers: 55 funds closed out of HELP and 5 opened new positions — a net loss of 50 holders — while 18 trimmed existing stakes and 10 added.
The largest buyer was Rosalind Advisors, adding an estimated $5.61M. The largest seller was RA Capital Management, exiting entirely with an estimated $11.9M sold.
- 46 institutional investors held Helus Pharma Inc. Common Stock (HELP) as of Q3 2024, down from 98 in Q2 2024.
- Funds reported $64.6M of Helus Pharma Inc. Common Stock stock for Q3 2024, down 18% quarter-over-quarter.
- 5 funds opened new Helus Pharma Inc. Common Stock positions in Q3 2024 and 55 closed out, a net change of -50 holders.
- The largest Helus Pharma Inc. Common Stock buyer in Q3 2024 was Rosalind Advisors, an estimated $5.61M added.
- The largest Helus Pharma Inc. Common Stock seller in Q3 2024 was RA Capital Management, an estimated $11.9M sold.
Based on aggregated 13F filings for Q3 2024.